Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Study Comparing Trabectedin (T) Versus T Plus tTF-NGR to Entrap T Inside the Tumor in Patients With Metastatic and/or Refractory Soft Tissue Sarcoma (STS)

NCT05597917 is registered in ClinicalTrials.gov with Universität Münster as lead sponsor.

NCT NCT05597917
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05597917 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Study Comparing Trabectedin (T) Versus T Plus tTF-NGR to Entrap T Inside the Tumor in Patients With Metastatic and/or Refractory Soft Tissue Sarcoma (STS)
Lead sponsor
Universität Münster
Phase
Phase 3
Overall status
Recruiting
Start date
October 26, 2021
Completion date
December 31, 2026
Enrollment
126 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

soft tissue sarcoma